A mathematical model for the laser treatment of heart disease

被引:8
作者
Waters, SL [1 ]
机构
[1] Univ Nottingham, Sch Math Sci, Div Appl Math, Sect Theoret Mech, Nottingham NG7 2RD, England
关键词
coronary artery disease; mathematical model; reperfusion;
D O I
10.1016/j.jbiomech.2003.08.003
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Transmyocardial laser revascularisation (TMLR) is used to treat patients with severe coronary artery disease. A laser is used to create narrow tunnels within ischemic heart muscle in an attempt to reperfuse the area with oxygenated blood directly from the left-ventricular chamber. It has been hypothesised that initially blood flow through the patent tunnels plays an important role in the efficacy of the treatment (J. Am. College Cordiol. 25(1) (1995) 258) and Waters (J. Fluid Mech. 433 (2001) 193) developed a simple mathematical model to show that this blood flow enhances the quantity of oxygenated blood drawn into the tunnel and the subsequent delivery of oxygen to the tissue. To date, however, the optimum parameter values for this clinical technique have not been determined, e.g. the radius of the laser-drilled tunnels and their relative spacing. We present a mathematical model to determine the distribution of oxygen for a wide range of the governing parameters. Our results indicate that the tunnel radius has a significant effect on the degree of tissue reperfusion and predictions for the optimum tunnel spacing are made. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:281 / 288
页数:8
相关论文
共 20 条
[1]  
BERWING K, 1997, CIRCULATION, V96, P1
[2]   Percutaneous myocardial laser revascularisation [J].
Clarke, SC ;
Schofield, PM .
HEART, 2000, 83 (03) :253-254
[3]   Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease [J].
Frazier, OH ;
March, RJ ;
Horvath, KA .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (14) :1021-1028
[4]  
HARDY RI, 1987, LASER SURG MED, V6, P563
[5]   Transmyocardial laser revascularization combined with vascular endothelial growth factor121 (VEGF121) gene therapy for chronic myocardial ischemia -: do the effects really add up? [J].
Heilmann, CAU ;
Altmann, T ;
von Samson, P ;
Göbel, H ;
Marmé, D ;
Beyersdorf, F ;
Lutter, G .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2003, 23 (01) :74-80
[6]   RECOVERY AND VIABILITY OF AN ACUTE MYOCARDIAL INFARCT AFTER TRANSMYOCARDIAL LASER REVASCULARIZATION [J].
HORVATH, KA ;
SMITH, WJ ;
LAURENCE, RG ;
SCHOEN, FJ ;
APPLEYARD, RF ;
COHN, LH .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 25 (01) :258-263
[7]   35 years of experimental research in transmyocardial revascularization: What have we learned? [J].
Huikeshoven, M ;
Beek, JF ;
van der Sloot, JAP ;
Tukkie, R ;
van der Meulen, J ;
van Gemert, MJC .
ANNALS OF THORACIC SURGERY, 2002, 74 (03) :956-970
[8]   Laser-tissue interaction during transmyocardial laser revascularization [J].
Jansen, ED ;
Frenz, M ;
Kadipasaoglu, KA ;
Pfefer, TJ ;
Altermatt, HJ ;
Motamedi, M ;
Welch, AJ .
ANNALS OF THORACIC SURGERY, 1997, 63 (03) :640-647
[9]  
Kadipasaoglu KA, 1997, LASER SURG MED, V20, P6, DOI 10.1002/(SICI)1096-9101(1997)20:1<6::AID-LSM2>3.0.CO
[10]  
2-U